MedPath

Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006

Completed
Conditions
New Strategies
GINA 2006
Patient Opinion
Registration Number
NCT00695357
Lead Sponsor
AstraZeneca
Brief Summary

Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
832
Inclusion Criteria
  • Patients diagnosed with persistent asthma (GINA 2005) for at least 6 months before entering the study
  • Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study
Read More
Exclusion Criteria
  • Patients who are not willing to sign the Informed Consent Form
  • COPD Patients
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage (%) of Asthma treatment satisfaction and control gradingsingle visit / once
Secondary Outcome Measures
NameTimeMethod
Rate of treatment compliancesingle visit / once
Patients quality of life under treatmentsingle visit / once

Trial Locations

Locations (1)

Research Site

🇬🇷

Xalkida, Greece

© Copyright 2025. All Rights Reserved by MedPath